VIA
ANIP icon

Virtus Investment Advisers’s ANI Pharmaceuticals ANIP Stock Holding History

Virtus Investment Advisers’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,319
Closed -$681K – 490
2024
Q4 		$681K Hold
12,319
– – 0.53% 45
2024
Q3 		$735K Hold
12,319
– – 0.58% 47
2024
Q2 		$784K Hold
12,319
– – 0.66% 39
2024
Q1 		$852K Hold
12,319
– – 0.61% 41
2023
Q4 		$679K Hold
12,319
– – 0.51% 47
2023
Q3 		$715K Buy
+12,319
New +$711K 0.49% 50

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Virtus Investment Advisers's ANIP Position: Q1 2025 in Review

Virtus Investment Advisers sold out of ANI Pharmaceuticals (ANIP) in Q1 2025, closing a stake of 12,319 shares — an estimated $681K sold.

Virtus Investment Advisers first reported a position in ANIP in Q3 2023 and held it in 6 quarters. The position peaked at $852K in Q1 2024. 230 funds tracked by Wall St. Rank hold ANIP as of Q1 2025.

  • Virtus Investment Advisers reported no remaining ANI Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 12,319 ANI Pharmaceuticals shares in Q1 2025, an estimated $681K.
  • Virtus Investment Advisers first reported a position in ANI Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Virtus Investment Advisers's ANI Pharmaceuticals position peaked at $852K in Q1 2024.
  • 230 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.